`Redundant' NICE to play a more advisory role under VBP system

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.616, 2010-01, pp. : 3-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

NICE, nursing and the NHS: more news from the UK

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 259, 2000-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

NICE wants more info on rivaroxaban for AF . . .

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 645, 2012-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

NICE has increased its capacity for appraising new drugs and treatments, and will be able to review existing NICE appraisals more quickly

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 592, 2009-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Scottish system better than NICE, claims chairman

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 582, 2009-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Could mitochondrial dysfunction play a role in manganese toxicity?

By Brown S. Taylor N.L.

Environmental Toxicology and Pharmacology, Vol. 7, Iss. 1, 1999-03 ,pp. : 49-57

Elsevier

Access to resources Recommend Favorite